Showing results (581-590 of 615) with videos related to

Sort By:
Pageof 62
Blood|July 10, 1998
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phaseA J Morton, T Gooley, J A Hansen, et al.
The New England Journal of Medicine|February 10, 1983
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environmentR Storb, R L Prentice, C D Buckner, et al.
Current Eye Research|March 1, 1997
Quasielastic light scattering study of the living human lens as a function of ageG M Thurston, D L Hayden, P Burrows, et al.
Blood|June 1, 1997
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell doseJ Sierra, B Storer, J A Hansen, et al.
Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.
Blood|March 1, 1981
Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twinsA Fefer, M A Cheever, E D Thomas, et al.
Frontiers in Bioscience : a Journal and Virtual Library|August 7, 2001
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st centuryM Maris, A Woolfrey, P A McSweeney, et al.
Blood|April 1, 1983
Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?R Storb, R L Prentice, M Banaji, et al.
Bone Marrow Transplantation|November 8, 2011
Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term resultsJ D Bowen, G H Kraft, A Wundes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantationK M Sullivan, E Kansu, B Storer, et al.
Pageof 62